Pharmacology · Autonomic Nervous System (Cholinergic, Anticholinergic, Sympathomimetics, Sympatholytics)

Dobutamine is used in cardiogenic shock to increase cardiac output. Its predominant mechanism of benefit is activation of which receptor?

  • A Alpha-1 adrenoceptor, increasing systemic vascular resistance
  • B Dopamine D1 receptor, causing renal vasodilation
  • C Beta-1 adrenoceptor, increasing myocardial contractility
  • D Beta-2 adrenoceptor, causing bronchodilation
Correct answer: C. Beta-1 adrenoceptor, increasing myocardial contractility

Explanation

Dobutamine is a synthetic catecholamine with predominant beta-1 agonist activity, producing positive inotropy with modest chronotropy and a slight decrease (via beta-2) in systemic vascular resistance—making it ideal in cardiogenic shock where raising contractility without markedly increasing afterload is desired. It does not act primarily on alpha-1 (minimal pressor effect) or D1 receptors (fenoldopam and dopamine at low dose mediate renal vasodilation via D1).

Reference: KD Tripathi, Essentials of Medical Pharmacology, 8th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Autonomic Nervous System (Cholinergic, Anticholinergic, Sympathomimetics, Sympatholytics) MCQs

See all Autonomic Nervous System (Cholinergic, Anticholinergic, Sympathomimetics, Sympatholytics) MCQs →